Screening for aneuploidy

M. I. Evans, J. E. O'Brien, A. Johnson

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Over the past 15 years, biochemical screening for chromosomal abnormalities, particularly Down's syndrome, has advanced from being extremely naive, to now somewhat more sophisticated. Sensitivities have gone from 20% to 60-70%. Considerable work is still required to not only increase the sensitivity, but also the specificity to keep health care costs down.

Original languageEnglish
Pages (from-to)115-118
Number of pages4
JournalCurrent Opinion in Obstetrics and Gynecology
Issue number2
StatePublished - 1999
Externally publishedYes


Dive into the research topics of 'Screening for aneuploidy'. Together they form a unique fingerprint.

Cite this